May 04

Evolution of the development, regulation and use of biosimilars

11:40 – 12:10 – Poster pitch
TECHNOLOGICAL DEVELOPMENT AND INNOVATION TO CONTROL TO ENDEMIC INFECTIOUS DISEASES
• IVD-02 – Kit NAT PLUS HIV/HBV/HCV/Malária Bio-Manguinhos: Innovation and technological upgrade for NAT, Daniele Ramos Rocha, Fiocruz/Bio-Manguinhos
• ORT-04 – Evaluation of three antigens for the use in immunochromatographic rapid test for serological diagnosis of Human Visceral Leishmaniasis in Brazil, Allana Kelly Oliveira Dutra, Fiocruz/Bio-Manguinhos
• IVD-08- Evaluation of Influenza A and SARS-CoV2 detection using RT-PCR by paired saliva and nasopharyngeal secretions samples, Pedro Henrique Cardoso, Fiocruz/Bio-Manguinhos

12:20 – 12:50 – Poster pitch
VIRUSES – FROM RAPID TEST TO MULTIPLEX ASSAY
• IVD-03 – A flow cytometry-based assay to measure neutralizing antibodies against SARS-CoV-2 virus, Veridiane Maria Pscheidt – UFCSPA
• ORT-09 – Usefulness of rapid molecular assay to detect hepatitis C virus, Vanessa Duarte da Costa, Fiocruz/IOC
• IVD-07 – Development of a multiplex RT-PCR molecular assay for Measles and Rubella viruses detection, Monica Barcellos Arruda, Fiocruz/Bio-Manguinhos

Cancer diagnosis and core demands
• Diagnostics by sequencing and digital PCR. What can we expect? Ilana Zalcberg, INCa*
• Real-time PCR and digital PCR applied to cancer diagnosis, John Young Lee, OPTOLANE Technologies Inc.*
Chair: Patricia Alvarez da Silva Baptista, Bio-Manguinhos*

Poster Oral Presentation 5 (IVD)
• IVD-01 – Detection of Plasmodium spp. in asymptomatic blood donors at Brazilian blood centers by the NAT PLUS HIV/HBV/HCV/MALARIA Bio-Manguinhos kit, Beatriz Vasconcello de Souza Barreto, Fiocruz/Bio-Manguinhos

Poster Oral Presentation 6 (ORT)
• ORT-01 – A high content image-based assay for detection and measurement of SARS-CoV-2 neutralizing antibodies, Vinicius Pinto Costa Rocha, SENAI CIMATEC

14:40 – 15:10 – Poster pitch – INFECTIOUS DISEASES
• ORT-05 – Evaluation of mutations in ABCB1 and ABCB11 genes by qPCR and their impact on the clinical evolution of hepatitis C, Leticia Bomfim Campos, Fiocruz/Instituto Oswaldo Cruz
• ORT-06 – Thiourea Derivatives with Antimycobacterial and Anti-Inflammatory Activity as an Adjuvant Treatment Strategy for Severe Pulmonary Tuberculosis, Sanderson Dias Calixto, UENF
• BIO-02 – Effect of lactoferrin as an immunomodulator and gene regulation of ferritin in different tissues of K18- hACE2 mice infected with SARS-CoV-2, Andrea Marques Vieira Da Silva – Fiocruz/Bio-Manguinhos

One Health and preparedness for the next pandemic
• A. Alonso Aguirre, Colorado State University*
• Mariangela Simão, Instituto Todos Pela Saúde*
• Ann-Muriel Steff, CEPI*
• Patricia Oliveira Pereira Tagliari, Anvisa*
Chair: Akira Homma, Bio-Manguinhos